Qube Research & Technologies (QRT)
CLGN icon

Qube Research & Technologies (QRT)’s CollPlant Biotechnologies CLGN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CLGN Stock Details CLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6
Closed -$30 – 3409
2024
Q2 		$30 Hold
6
– – ﹤0.01% 3549
2024
Q1 		$32 Hold
6
– – ﹤0.01% 4239
2023
Q4 		$38 Hold
6
– – ﹤0.01% 4092
2023
Q3 		$34 Buy
+6
New +$40 ﹤0.01% 3845

Other funds holding CLGN

PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $10.1B AUM 14.03% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CLGN Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of CollPlant Biotechnologies (CLGN) in Q3 2024, closing a stake of 6 shares — an estimated $30 sold.

Qube Research & Technologies (QRT) first reported a position in CLGN in Q3 2023 and held it in 4 quarters. The position peaked at $38 in Q4 2023. 13 funds tracked by Wall St. Rank hold CLGN as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining CollPlant Biotechnologies position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 6 CollPlant Biotechnologies shares in Q3 2024, an estimated $30.
  • Qube Research & Technologies (QRT) first reported a position in CollPlant Biotechnologies in Q3 2023 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s CollPlant Biotechnologies position peaked at $38 in Q4 2023.
  • 13 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.